๐Ÿ”ฌDeep Research

CDNA โ€” CareDx ยท catalysts, narrative & risks

ยท20 sourcesCDNA forecast โ†’

CareDx (CDNA) โ€” Research Snapshot as of 2026-10-03

Company context: CareDx is a Nasdaq-listed precision-medicine diagnostics company focused on genomics-based transplant diagnostics, testing services, products, and digital solutions [20]. As of early October 2026 it carries a market capitalization near $3.4โ€“3.5B and trades in the high-$60s (e.g., $67.15 on Oct 2, 2026) [5][6][20].

Key Recent Catalysts (last ~1โ€“3 months)


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’